|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 239/42 | (2006.01) |
| C07D 239/84 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 475/00 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2872491 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13740458.8 |
| Date of filing the European patent application | 2013-07-11 | |
| (97) | Date of publication of the European application | 2015-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation | 2021-08-25 |
| (86) | Number | PCT/US2013/050106 |
| Date | 2013-07-11 |
| (87) | Number | WO 2014/011900 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261670379 P | 2012-07-11 | US | |
| 201261746666 P | 2012-12-28 | US |
| (72) |
BIFULCO, Neil, Jr., US
BROOIJMANS, Natasja, US
HODOUS, Brian, L., US
KIM, Joseph, L., US
MIDUTURU, Chandrasekhar, V., US
WENGLOWSKY, Steven Mark, US
|
| (73) |
Blueprint Medicines Corporation,
45 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Vitalija BANAITIENÄ–,
UAB TARPINÄ–, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Fibroblasto augimo faktoriaus receptoriaus inhibitoriai |
| INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 13 | 289.00 EUR |
| 2026-07-11 |